Urine telomerase: An important marker in the diagnosis of bladder cancer

Neoplasia

Volumn 6, Issue 3, 2004, Pages 234-239

  Sanchini, Maria Aurora ^a   Bravaccini, Sara ^a   Medri, Laura ^a   Gunelli, Roberta ^a   Nanni, Oriana ^a   Monti, Franco ^b   Baccarani, Paolo Carlo ^b   Ravaioli, Alberto ^b   Bercovich, Eduard ^a   Amadori, Dino ^a   Calistri, Daniele ^a,c  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b INFERMI HOSPITAL   (Italy)

^c Ospedale Pierantoni   (Italy)

Author keywords

Bladder tumor; Diagnosis; Monoclonal antibody; Telomerase; Urine

Indexed keywords

MONOCLONAL ANTIBODY; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR MARKER;

ADULT; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; FEMALE; GENDER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; URINALYSIS; URINE CYTOLOGY;

EID: 2442720108     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.03433     Document Type: Article

References (34)

1. Muller M (2002). Telomerase: its clinical relevance in the diagnosis of bladder cancer. Oncogene 21, 650-655.
2. Raab SS, Lenel JC, and Cohen MB (1994). Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis. Cancer 74, 1621-1626.
3. Kinoshita H, Ogawa O, Kakehi Y, Mishina M, Mitsumori K, Itoh N, Yamada H, Terachi T, and Yoshida O (1997). Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 89, 724-730.
4. Yoshida K, Sugino T, Tahara H, Woodman A, Bolodeoku J, Nargund V, Fellows G, Goodison S, Tahara E, and Tarin D (1997). Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 79, 362-369.
5. Kavaler E, Landman J, Chang Y, Droller MJ, and Liu BC (1998). Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer 82, 708-714.
6. Yokota K, Kanda K, Inoue Y, Kanayama H, and Kagawa S (1998). Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma. Br J Urol 82, 727-732.
7. Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wolian PC, Blute ML, and O'Kane DJ (1999). Comparison of screening methods in the detection of bladder cancer. J Urol 161, 388-394.
8. Chao D, Freedland SJ, Pantuck AJ, Zisman A, and Belldergrun AS (2001). Bladder cancer 2000: molecular markers for the diagnosis of transitional cell carcinoma. Rev Urol 3, 85-93.
9. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, and Shay JW (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
10. Wright WE, Piatyszek MA, Rainey WE, Byrd W, and Shay JW (1996). Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18, 173-179.
11. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, and Yamakido M (1995). Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155, 3711-3715.
12. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, and Cech TR (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959.
13. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, and Shay JW (1996). Detection of telomerase activity in malignant and non-malignant skin conditions. J Invest Dermatol 106, 759-765.
14. Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW, and Yokoyama T (1996). Telomerase activity in human intestine. Int J Oncol 9, 453-458.
15. Holt SE, Wright WE, and Shay JW (1996). Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16, 2932-2939.
16. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews CW, Greider CW, and Villeponteau B (1995). The RNA component of human telomerase. Science 269, 1236-1241.
17. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, and Robinson MO (1997). A mammalian telomerase-associated protein. Science 275, 973-977.
18. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, and Weinberg RA (1997). hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785-795.
19. Shay JW and Gazdar AF (1997). Telomerase in the early detection of cancer. J Clin Pathol 50, 106-109.
20. Wright WE, Shay JW, and Piatyszek MA (1995). Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23, 3794-3795.
21. Fedriga R, Gunelli R, Nanni O, Bacci F, Amadori D, and Calistri D (2001). Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine. Neoplasia 3, 446-450.
22. Deeks JJ (2001). Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 323, 157-162.
23. Gelmini S, Crisci A, Salvadori B, Pazzagli M, Selli C, and Orlando C (2000). Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. Clin Cancer Res 6, 2771-2776.
24. Dalbagni G, Han W, Zhang ZF, Cordon-Cardo C, Saigo P, Fair WR, Herr H, Kim N, and Moore MA (1997). Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res 3, 1593-1598.
25. Ito H, Kyo S, Kanaya T, Takakura M, Inoue M, and Namiki M (1998). Expression of human telomerase subunits and correlation with telomer-ase activity in urothelial cancer. Clin Cancer Res 4, 1603-1608.
26. Landman J, Chang Y, Kavaler E, Droller MJ, and Liu BC (1998). Sen-sitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer. Urology 52, 398-402.
27. Lee DH, Yang SC, Hong SJ, Chung BH, and Kim IY (1998). Telomer-ase: a potential marker of bladder transitional cell carcinoma in bladder washes. Clin Cancer Res 4, 535-538.
28. Muller M, Krause H, Heicappell R, Tischendorf J, Shay JW, and Miller K (1998). Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer. Clin Cancer Res 4, 1949-1954.
29. Ohyashiki K, Yahata N, Ohyashiki JH, Iwama H, Hayashi S, Ando K, Aizawa T, Ito T, Miki M, and Ebihara Y (1998). A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of ur-othelial neoplasia. Cancer 83, 2554-2560.
30. Hirose M, Abe-Hashimoto J, Ogura K, Tahara H, Ide T, and Yoshimura T (1997). A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol. J Cancer Res Clin Oncol 123, 337-344.
31. Kim NW and Wu F (1997). Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 25, 2595-2597.
32. Gelmini S, Caldini A, Becherini L, Capaccioli S, Pazzagli M, and Orlando C (1998). Rapid, quantitative nonisotopic assay for telomerase activity in human tumors. Clin Chem 44, 2133-2138.
33. Yahata N, Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Ando K, Hirano T, Tsuchida T, Kato H, Shay JW, and Toyama K (1998). Telomerase activity in lung cancer cells obtained from bronchial washings. J Natl Cancer Inst 90, 684-690.
34. Hiyama E and Hiyama K (2002). Clinical utility of telomerase in cancer. Oncogene 21, 643-649.